U.S. Patent Attorney Mi Cai will speak at the IP ForeFront Pharma Forum 2026 (IFPF 2026) in Shanghai. On the morning of September 16, she will present on "IP Due Diligence for China-Origin Therapeutic Assets in Cross-Border Transactions." She will provide practical frameworks for evaluating IP assets originating in China as they move into U.S. and global deal structures.
On the afternoon of September 16, she will join a panel discussion on "Offensive and Defensive Games in Conjugate Drug Patents – From Tri-Regional Examination Practices to Overseas Litigation Risks." She and her fellow panelists will share insights on how examination standards across China, the U.S., and Europe create both opportunities and vulnerabilities for companies building global patent portfolios for conjugate drugs (including ADCs).
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
